卡那努马布
医学
耐受性
内科学
阿纳基纳
疾病
不利影响
作者
Takayuki Miyamoto,Kazushi Izawa,Sho Masui,Atsue Yamazaki,Yuichi Yamasaki,Tadashi Matsubayashi,Mayuka Shiraki,Hidenori Ohnishi,Junko Yasumura,Tomohiro Kawabe,Takako Miyamae,Tomoyo Matsubara,Naoya Arakawa,Takashi Ishige,Takumi Takizawa,Asami Shimbo,Masaki Shimizu,Naoki Kimura,Yuichi Maeda,Y. Maruyama
摘要
We assess the clinical characteristics of patients with cryopyrin-associated periodic syndrome (CAPS) in Japan and evaluate the real-world efficacy and safety of interleukin-1 (IL-1) inhibitors, primarily canakinumab.
科研通智能强力驱动
Strongly Powered by AbleSci AI